Drug Development

Apr 17, 2017
By Pharmaceutical Technology Editors
The two companies will develop translational biomarkers for fibrotic diseases, including non-alcoholic steatohepatitis (NASH).
Apr 07, 2017
By Pharmaceutical Technology Editors
A drop in US drug approvals was noted but this trend was not yet seen in Europe.
Apr 06, 2017
FDA is in the center of the debate over developing and pricing new cancer therapies.
Apr 02, 2017
Pharmaceutical Technology
Interpretation of calorimetric data is tricky. The author suggests 10 questions that should be asked of any calorimetric method, along with the rationales behind them.
Apr 02, 2017
Pharmaceutical Technology
Anil Kane, executive director, Global Head of Formulation Sciences, Pharmaceutical Development Services at Patheon discusses key parameters in the development and manufacturing of oral solid-dosage forms.
Apr 02, 2017
Pharmaceutical Technology
David Fulper, PhD, director of technology support at Catalent, shares insights on the challenges and opportunities for cannabis-based therapeutics.
Apr 02, 2017
Pharmaceutical Technology
Design of experiment plays a crucial role in the optimization process of formulation development.
Mar 29, 2017
By Pharmaceutical Technology Editors
Under the agreement, Laurus Synthesis will provide chemistry development services and manufacturing in support of an upcoming clinical trial evaluating EPX-100 in adolescents suffering from Dravet syndrome.
Mar 27, 2017
By Pharmaceutical Technology Editors
The Basel office will house the clinical development team and other functions to progress the company’s lead compound emapalumab.
Mar 16, 2017
By Pharmaceutical Technology Editors
Human antibody for Zika virus could help in the treatment and prevention of the infection.
native1_300x100
lorem ipsum